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Abstract
Using ethnographic examples of medicine use, prescription, distribution and production, the
authors argue that social and cultural effects of pharmaceuticals should be taken into account. Non-
medical effects deeply influence the medical outcome of medicine use. Complications around the
advent of anti-AIDS medicines in poor countries are taken as a point in case. The authors are
medical anthropologists specialised in the social and cultural analysis of pharmaceuticals.
Background
As anthropologists studying medicines we look at medi-
cines as social and cultural phenomena. We do not ignore
or overlook their therapeutic function, but want to draw
attention to aspects that usually are  overlooked: their
social, cultural, economic, religious and emotional
effects. Medical and non-medical effects are not unrelated,
however; together they form the total drug effect. They
may reinforce each other (placebo effect) or work against
each other (nocebo effect).
Some years ago, we [1,2] used a popular anthropological
metaphor to capture the social and cultural dimension of
medicines, Appadurai's concept of 'Social Life of Things'
[3]. Things acquire meaning, when they enter into the life
of people. There begins their 'social life'. Nothing (no-
thing) coincides completely with its material qualities.
Every-thing transcends its rustic entity and assumes social,
cultural, psychological (etc.) roles in the world of human
beings. Things are bound to be semiotic (having symbolic
meanings). That semiotic quality is likely to grow if
objects are more valuable.
Medicines are a good example of valuable things that
assume a wide variety of meanings, far beyond their mate-
rial (chemical) properties. We have tried to illustrate this
in our book by looking at medicines in the hands of dif-
ferent actors: consumers, such as patients and caretakers,
providers (pharmacists, drug vendors, physicians), pro-
ducers and what we could call 'paper workers'. Let us look
more closely at some of these actors.
Mothers in Manila
In one chapter we describe how mothers in a poor area of
Manila give medicines to their children when they suffer
from coughs or colds [4]. After discussing the mothers'
ideas about coughs and colds and how they should be
treated (quite different from biomedical knowledge), the
chapter points at ideas that underlie these narratives of
causation and therapy; that is concerns about the vulner-
ability of children. Children need protection and parents
should be responsible. If children are ill often, people
tend to talk about their mothers as negligent. Cough, as
Tan observes, is considered undesirable and blameworthy
in the urban poor communities. He cites a young mother
who describes this graphically: '..if the cough is continu-
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ous, (the child's) father is disturbed. When he comes back
from work, and is hot headed, then he hears the child
coughing... Because I am the mother, if the child is sick, I
am blamed.' [5]. Tan argues that it is not surprising that
the manufacturers of cough and cold medicines empha-
size a hacking dry cough in their advertising. The dry
cough conveys not just the image of lungs bursting from
the strain, but also the potential of social disruption.
The idea that children usually recover without medicines
has no chance in such a situation. The social context
demands the use of medicines. The effects of those medi-
cines are therefore manifold:
• They may help to cure the child faster.
￿ They confirm to the mother that she is a good mother.
￿ They send a message to the child that the mother cares.
￿ They communicate that same message to the husband,
neighbours and others.
￿ And all these messages together reinforce the health
restoring effect on the sick child.
Women in distress
In her study 'Rituals of Silence' Haafkens [6] examines the
use of benzodiazepines – medicines prescribed for mental
distress – by women in the Netherlands. She describes
how the medicines not only make it possible for women
to live on with their mental health problems, but also pro-
vide society with a means to control anxiety and stress.
The ambiguous relation between self-control of female
distress and medicalised social control of life problems is
the main theme of another chapter in our book.
On the one hand, women use benzodiazepines like other
medicines to enhance the quality of their individual lives.
Medicines liberate them from bodily discomfort, and give
them means to control natural bodily processes such as
conception, menstruation and menopause. Medicines are
part of day-to-day body regimes, in which women strive to
fulfill societal expectations of work capability, appropriate
fertility, attractive appearance, and mental stability.
On the other hand, benzodiazepines and other medicines
also function as a medical means of social control. In
modern societies, where medicine has replaced religion as
a dominant moral ideology and social control institution,
more and more of everyday life has come under medical
dominion, influence and supervision, a process known as
medicalisation.
Around 1990, at the time of Haafkens' study, about one in
every seven women had a prescription for benzodi-
azepines filled annually in the Netherlands; men received
such prescriptions much less often. Dutch medical guide-
lines acknowledged that the drugs were not as safe as ini-
tially thought, and recommended that the duration of
benzodiazepine use be limited to one to two weeks, a few
months at the most. Despite this advice, long-term use of
benzodiazepines remained relatively common in the
Netherlands, affecting an estimated three percent of the
Dutch population.
The efficacy of the medicines, therefore, is ambiguous. For
the women who use them, the medicines are indispensa-
ble to stay in control of their lives. At the same time, many
of those using them feel that the medicines have taken
control of them. They would like to stop but cannot. The
medicines are empowering as well as disempowering.
Prescribing doctors
The third example is taken from research in Sri Lanka. Lis-
beth Sachs, a Swedish anthropologist, did fieldwork in a
rural health unit. She followed 50 patients before, during
and after their encounter with the doctor.
Sachs made a remarkable discovery. Doctors and patients
hardly communicated with one another. The practitioner
did not hear the patient's complaint and the patient did
not understand the doctor's diagnosis but – miraculously
– both parties felt satisfied about the encounter, which
always ended in a prescription.
In the interview before the encounter with the doctor,
patients described their problems in Ayurvedic terms,
mentioning symptoms like heat escaping from the body,
dry phlegm, yellow vomit and loss of semen, but during
the consultation many of these symptoms were never
mentioned. Instead of 'burning feeling' or 'heat behind
the eyes' the patient would just say 'fever' and instead of
'too much phlegm', he would say 'cough'. The doctor who
had very little, if any, time for communication would
immediately make a biomedical diagnosis and write a
prescription which was '...committed to paper without
any evidence ...of an examination, few spoken words and
little, if any, eye or body contact' [7]. Then the next patient
was called.
Interestingly, the patients usually did not feel neglected or
misunderstood; their respect for the doctor's expertise
made them accept the doctor's verdict as the right decision
and the doctor in turn, felt that she had done a good job.
Sachs writes:
The mutual confidence of practitioners and patients in the
medicines helps prevent the misunderstanding of eachJournal of Ethnobiology and Ethnomedicine 2006, 2:48 http://www.ethnobiomed.com/content/2/1/48
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other's beliefs from being uncovered. This confidence
imbues the medicines with a magic, symbolic aura, giving
the practitioners as well as the patients a feeling that they
contribute in their way to solving the acute health prob-
lem.... Within the therapeutic encounter then, there exists
two different systems of knowledge through which the
effectiveness of these medicines is integrated. The contra-
dictory symbolic meanings of the medicines remain unre-
vealed, allowing patients and practitioners to
communicate in a satisfactory manner [7].
Sachs describes prescribing medicines as an act which cre-
ates the illusion of communication and which results in
satisfaction among both patients and doctors. It reveals
five facets of prescription. Firstly, prescribing medicines is
a way of dealing with uncertainty; often the doctor and
the patient do not know the exact nature of the complaint
nor what to do about it. Yet prescribing a medicine allevi-
ates that uncertainty and gives both parties a feeling of
having dealt with the problem.
Secondly, prescribing is a token of concern on the part of
the doctor. It shows that the doctor is a good doctor. Far
from being an anonymous commodity, the medicine
becomes a symbolic representation of the person of the
doctor. Such a positive reception of medicine creates an
ideal condition for recovery.
Thirdly, prescribing is the prerogative of doctors. It is an
act in which they express and reaffirm their authority over
patients and over professional colleagues such as nurses
and pharmacists who are not supposed to write a prescrip-
tion.
Fourthly, the prescription itself, a tiny hand-written docu-
ment, deserves our attention. It shares with other types of
scripts the capacity to objectify, concretise and visualise.
The prescription is one of the most cherished parapherna-
lia of the doctor expressing his superior knowledge and
authority, but as an inscription, it is highly significant for
the patient as well.
Finally, for the doctors in Sri Lanka, who have hardly any
time to lose due to the large number of patients, prescrib-
ing is a ritual and effective way to manage the length of the
consultation firmly by cutting it off and at the same time
letting the patient leave in a positive mood.
Manufacturers of medicines
Few anthropologists have succeeded in doing research in
the laboratories and offices of the pharmaceutical indus-
try. One who did manage to do so is Maarten Bode [8]
who studied the culture of production and sale of
Ayurvedic and Unani medicines in India. Bode shows that
these medicines become symbols of an ambivalent Indian
cultural identity. On the one hand they are presented as
being rooted in ancient knowledge, which is very different
from Western traditions; on the other hand, these medi-
cines in their present-day form (capsules, pills, etc) are
signs of modernity.
Bode also points out that the pharmaceutical companies
he studied not only produce medicines, but also ideas
about medicines in the form of quasi-scientific knowl-
edge. These ideas have mainly two functions: they con-
firm to the producers themselves that their products are
indeed wholesome and effective and they establish scien-
tific claims that should boost their products in interna-
tional competition. ' Western' pharmaceutical companies
may not act very differently in this respect. They sell the
disease before selling the drugs, as Healy [9] remarked in
a study of a company producing medicines against panic
attacks. The company exerted its influence on academic
writing and sponsored scientific conferences. Healy sug-
gests that a large, but of course unknown, percentage of
the scientific output in scientific journals may now be
ghost-written by agents of the industry. Bode, in his
Ayurvedic study, emphasises the ritual purpose of scien-
tific testing. The tests do not stand the test of scientific rig-
our but serve promotional purposes.
Policymakers
The term 'policymakers' suggests that these people make
policy. This would, with regard to medicines, mean that
they plan and organise a fair and efficient distribution of
medicines. We prefer a less optimistic, somewhat ironic,
definition of policymakers. We see them first of all as pro-
ducers of paper documents that speak about efficient and
equitable medicine distribution. The culture of policy-
making is mainly a paper culture. The task of a policy-
maker is to write texts before a certain deadline and get
them accepted by those who carry political authority.
Medicines are for them words on paper. About one and a
half decades ago, a team of researchers was to evaluate the
WHO's Essential Drugs Programme in a selection of
developing countries. The team did not investigate
whether essential medicines were indeed available and
used at all levels of the selected societies. The investigators
limited themselves to the question whether and how fre-
quently the term 'essential medicines' occurred in relevant
government documents.
The real medicines play only a secondary role; they come
after their paper metonyms. A de facto fair and steady dis-
tribution of medicines would be a significant political
achievement and lend credibility to a government. It
would be one of the most convincing proofs of good gov-
ernance: a government caring for the health of its popula-
tion as a mother for her children. Medicines are often seen
as the hard core of good health care, so one would expectJournal of Ethnobiology and Ethnomedicine 2006, 2:48 http://www.ethnobiomed.com/content/2/1/48
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policymakers to grab that chance and make sure that peo-
ple get their medicines. It happens amazingly little in low-
income countries. During research in Cameroon Van der
Geest found that shortages of medicines in public hospi-
tals and health centres had become proverbial tokens of
the government's inefficiency, lack of commitment and
corruption. The policymakers did not seem to care. Their
paper work was perfect [10].
Finally, we must acknowledge that planning medicine dis-
tribution is not so easy. Medicines, as we have seen, have
commercial, social and other values, which draw them
out of the control of medical planning [11]. Medicines
lead their own social lives and do not listen to the direc-
tives of the Ministry of Health. No policymaker could pre-
vent that a laxative became the most popular
contraceptive in Ghana when Van der Geest did research
in that country. Most were not even aware of it. And no
policymaker will be able to control the distribution of
anti-AIDS medicines in Africa today.
Anthropologists
For anthropologists too medicines are first of all a topic to
write about in books and articles that are read and com-
mented upon by colleagues and that are presented and
discussed at conferences. For anthropologists, medicines
provide a fascinating case to study the working of culture.
In the social lives of medicines all themes that interest
anthropologists seem to come together: surviving strate-
gies, social relationships, power and inequality, poverty
and affluence, belief, economic rationality, embodiment,
symbolism and globalisation, to mention only a few. Par-
aphrasing Lévi-Strauss we can say that medicines are good
to write about.
But medicines also allow anthropologists to leave their
paper world and apply the results of their research in con-
crete situations of health care. Medicines have intrigued
anthropologists, and fuelled their imagination, yet ideas
and practices around medicines were not simply data to
be analysed. They were concerned about health problems
and they felt that what they had learned had implications
for health professionals and policy makers. But they did
not necessarily think that their knowledge should be used
simply to facilitate their agendas. Rather they wanted to
use it to interrogate public health paradigms and profes-
sional practice, to draw attention to blind spots and
biases, including the neglect of consumer agency. They
also wanted, at times, to go beyond analysis and critique,
to engage themselves in concrete projects of action.
Future social science research on medicines
Let us now propose a few themes for future social science
research on medicines.
￿ We should pay more attention to the non-medical
meanings and effects of medicines, as we have just
attempted to do. Even if we are ultimately concerned
about a just provision and good use of medicines in
health care, we should study how social and other mean-
ings of medicines impinge on the quality of provision and
use. Medicines mean different things and serve different
interests to different people in different situations. No
prescriber or policymaker can afford to overlook that
complexity of medicines.
￿ We should be particularly attentive to the economic real-
ity of medicines. Medicines are commodities, and
extremely lucrative ones at that. If we want to understand
the ways of medicines, we should study the directions of
money. Recent discussions and developments regarding
the distribution of anti-AIDS medicines to poor countries
underscore how true this is [12,13].
￿ We want to emphasise the need for studying how our
knowledge of meaning and distribution of medicines can
be converted into practical use. To our colleagues in med-
ical anthropology we say that we should not hide in eso-
teric jargon or unintelligible 'thick description', but be
prepared to write 'thinly' and transparently. The applica-
bility of anthropological knowledge is a test for doing
research.
￿ Let us, to conclude, give one example of how our under-
standing of the non-medical aspects of medicines may
benefit our future health. We are referring to the arrival of
antiviral medication in low-income countries.
Antiretroviral medicines in low-income societies
The lowering of prices of antiretroviral therapy (ART) has
led to a global commitment to scale up access to these
drugs in resource poor settings, where until recently peo-
ple living with HIV and AIDS (PLWA) did not have access
to these life-prolonging drugs. Many different global
actors have committed funds for rapid distribution of
these drugs to people in need. The emphasis in the treat-
ment programs is on the pharmacological efficacies of
these drugs – they should be prescribed and used accord-
ing to strict guidelines. Adherence has to be ensured,
because non-adherence to ARV rapidly causes viruses to
become resistant to the drugs, requiring the patient to
switch to more expensive second-line therapies. The emer-
gence of drug resistance is not only a problem to the indi-
vidual, but also to society at large. It jeopardizes the
treatment of all PLWA. There are many socio-cultural and
psychological themes that require further studies, in addi-
tion to the biomedical studies done to optimise treatment
regimes.Journal of Ethnobiology and Ethnomedicine 2006, 2:48 http://www.ethnobiomed.com/content/2/1/48
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First, we need to understand how people understand the
efficacy of ARVs. Preliminary fieldwork in resource poor
settings suggests that users are initially very positive about
the drugs, but are constrained by treatment related costs
(including user-fees and transport costs). They tend to
start taking the medicines when they are severely ill, and
they experience rapid improvements in health [14-16].
However, many poor patients complain that the medi-
cines cause hunger. Access to food becomes an issue that
has not been sufficiently addressed in the treatment pro-
grams [14]. Also, some ARVs come with dietary restric-
tions (avoiding lipids, or taking ARVs at mealtime), which
can be difficult for patients to comply with in family set-
tings. The dietary restrictions can force them to disclose
their HIV status – they need to explain why their food hab-
its change [17]. Apart from the medical effects of the
drugs, there is a need to understand such social (side)
effects. There are not much data yet on long-term use of
ARVs in resource poor settings [18,19]. ARV combinations
can cause changes in fat-distribution in the body, gastro-
intestinal disturbances and liver problems. These side-
effects affect quality of life and can be stigmatising [20].
When after having taken ARVs for a few months, patients
feel better, they may be less inclined to tolerate these
(social) side-effects, resulting in treatment interruptions
or treatment discontinuation.
Another issue for anthropological research is the emer-
gence of many neo-traditional drugs for the prevention
and treatment of AIDS. These drugs emerged when ARVs
as life-prolonging treatment were not yet on accessible to
poor users. They operated in the treatment vacuum. Now
health workers advice patients not to use traditional med-
icines when taking ARVs, because of possible pharmaco-
logical interactions. Patients however consider these neo-
traditional medicines as complementary or even alterna-
tive to modern pharmaceuticals. More details on actual
use of remedies by PLWA is an important issue for further
research, but sensitive because of the health workers rejec-
tion of these other treatments.
ARVs are drugs with a high monetary value. This makes
their distribution and use an especially interesting theme
for medical anthropologists. What happens with these
valuable goods in the hands of people procuring, distrib-
uting, prescribing, dispensing and using them. Policy
makers are aware of this high value of the drugs, and they
are trying to control the distribution by means of compli-
cated reporting systems, but to what extent will this disci-
plining attempt succeed? Paper is patient, and reports can
be made about drugs supplies and prescriptions, when in
reality different things are going on. Such leakage of essen-
tial medicines has been poorly studied in the past. Stock-
outs are common with essential drugs, and they are likely
to occur to with ARVs. The problem being that for ARVs
the public health consequences are dramatic – it will con-
tribute to rapid emergence of resistances. Anthropologists
need to start studying the social lives of these valuable
things.
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